300878 维康药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.855-11.571-0.6423.4926.946
总资产报酬率 ROA (%)-0.599-7.939-0.4502.7065.809
投入资产回报率 ROIC (%)-0.674-8.857-0.4963.0016.618

边际利润分析
销售毛利率 (%)51.40138.18250.52358.85467.711
营业利润率 (%)-2.045-43.777-0.36612.18015.663
息税前利润/营业总收入 (%)-1.294-43.2860.17012.48515.324
净利润/营业总收入 (%)-13.911-41.253-1.3669.29315.253

收益指标分析
经营活动净收益/利润总额(%)435.503100.957599.87060.84095.034
价值变动净收益/利润总额(%)0.000-57.567-256.84923.4180.264
营业外收支净额/利润总额(%)35.6542.86471.479-2.6940.886

偿债能力分析
流动比率 (X)2.6782.5652.3612.5033.744
速动比率 (X)2.0772.0722.0152.2203.187
资产负债率 (%)28.98828.95931.69926.29816.789
带息债务/全部投入资本 (%)17.83717.68322.11816.9273.468
股东权益/带息债务 (%)441.559445.687338.007471.5422,683.577
股东权益/负债合计 (%)241.639241.938212.777277.632491.521
利息保障倍数 (X)-0.687-24.2940.11719.990-31.993

营运能力分析
应收账款周转天数 (天)181.968179.228167.576218.148187.383
存货周转天数 (天)339.034225.604189.431202.341186.537